173 related articles for article (PubMed ID: 19670450)
21. VEGF and EMMPRIN expression correlates with survival of patients with osteosarcoma.
Zhou Q; Zhu Y; Deng Z; Long H; Zhang S; Chen X
Surg Oncol; 2011 Mar; 20(1):13-9. PubMed ID: 19836228
[TBL] [Abstract][Full Text] [Related]
22. Vascular endothelial growth factor expression in untreated osteosarcoma is predictive of pulmonary metastasis and poor prognosis.
Kaya M; Wada T; Akatsuka T; Kawaguchi S; Nagoya S; Shindoh M; Higashino F; Mezawa F; Okada F; Ishii S
Clin Cancer Res; 2000 Feb; 6(2):572-7. PubMed ID: 10690541
[TBL] [Abstract][Full Text] [Related]
23. [Expression of hypoxia-inducible factor 1α in osteosarcoma and its value in predicting chemosensitivity].
Chen Y; Wang CM; Shi YQ; Yang Y
Zhonghua Zhong Liu Za Zhi; 2012 Dec; 34(12):899-904. PubMed ID: 23336375
[TBL] [Abstract][Full Text] [Related]
24. Expression of HER2/erbB-2 correlates with survival in osteosarcoma.
Gorlick R; Huvos AG; Heller G; Aledo A; Beardsley GP; Healey JH; Meyers PA
J Clin Oncol; 1999 Sep; 17(9):2781-8. PubMed ID: 10561353
[TBL] [Abstract][Full Text] [Related]
25. HB-EGF-induced VEGF production and eNOS activation depend on both PI3 kinase and MAP kinase in HaCaT cells.
Nakai K; Yoneda K; Moriue T; Igarashi J; Kosaka H; Kubota Y
J Dermatol Sci; 2009 Sep; 55(3):170-8. PubMed ID: 19559571
[TBL] [Abstract][Full Text] [Related]
26. Worse prognosis of osteosarcoma patients expressing IGF-1 on a tissue microarray.
Jentzsch T; Robl B; Husmann M; Bode-Lesniewska B; Fuchs B
Anticancer Res; 2014 Aug; 34(8):3881-9. PubMed ID: 25075009
[TBL] [Abstract][Full Text] [Related]
27. Expression of molecular markers in the tumor and survival prognosis in osteosarcoma.
Boulytcheva IV; Soloviev YN; Kushlinskii NE; Mahson AN
Bull Exp Biol Med; 2010 Dec; 150(2):237-42. PubMed ID: 21240382
[TBL] [Abstract][Full Text] [Related]
28. Activation of the Akt-mTOR pathway and receptor tyrosine kinase in patients with solitary fibrous tumors.
Yamada Y; Kohashi K; Fushimi F; Takahashi Y; Setsu N; Endo M; Yamamoto H; Tokunaga S; Iwamoto Y; Oda Y
Cancer; 2014 Mar; 120(6):864-76. PubMed ID: 24353015
[TBL] [Abstract][Full Text] [Related]
29. Increased expression of insulin-like growth factor-1 receptor is correlated with worse survival in canine appendicular osteosarcoma.
Maniscalco L; Iussich S; Morello E; Martano M; Gattino F; Miretti S; Biolatti B; Accornero P; Martignani E; Sánchez-Céspedes R; Buracco P; De Maria R
Vet J; 2015 Aug; 205(2):272-80. PubMed ID: 25257352
[TBL] [Abstract][Full Text] [Related]
30. Expression of Vascular Endothelial Growth Factor correlates with the advance of clinical osteosarcoma.
Lammli J; Fan M; Rosenthal HG; Patni M; Rinehart E; Vergara G; Ablah E; Wooley PH; Lucas G; Yang SY
Int Orthop; 2012 Nov; 36(11):2307-13. PubMed ID: 22855059
[TBL] [Abstract][Full Text] [Related]
31. Fas expression inversely correlates with metastatic potential in osteosarcoma cells.
Worth LL; Lafleur EA; Jia SF; Kleinerman ES
Oncol Rep; 2002; 9(4):823-7. PubMed ID: 12066216
[TBL] [Abstract][Full Text] [Related]
32. Vascular endothelial growth factor expression in osteosarcoma.
Charity RM; Foukas AF; Deshmukh NS; Grimer RJ
Clin Orthop Relat Res; 2006 Jul; 448():193-8. PubMed ID: 16826116
[TBL] [Abstract][Full Text] [Related]
33. mTOR/p70S6K signal transduction pathway contributes to osteosarcoma progression and patients' prognosis.
Zhou Q; Deng Z; Zhu Y; Long H; Zhang S; Zhao J
Med Oncol; 2010 Dec; 27(4):1239-45. PubMed ID: 19936974
[TBL] [Abstract][Full Text] [Related]
34. Mapping protein signal pathway interaction in sarcoma bone metastasis: linkage between rank, metalloproteinases turnover and growth factor signaling pathways.
Conti A; Espina V; Chiechi A; Magagnoli G; Novello C; Pazzaglia L; Quattrini I; Picci P; Liotta LA; Benassi MS
Clin Exp Metastasis; 2014 Jan; 31(1):15-24. PubMed ID: 23877430
[TBL] [Abstract][Full Text] [Related]
35. A systematic review of vascular endothelial growth factor expression as a biomarker of prognosis in patients with osteosarcoma.
Chen D; Zhang YJ; Zhu KW; Wang WC
Tumour Biol; 2013 Jun; 34(3):1895-9. PubMed ID: 23589053
[TBL] [Abstract][Full Text] [Related]
36. Expression and significance of TGF-beta isoform and VEGF in osteosarcoma.
Jung ST; Moon ES; Seo HY; Kim JS; Kim GJ; Kim YK
Orthopedics; 2005 Aug; 28(8):755-60. PubMed ID: 16119739
[TBL] [Abstract][Full Text] [Related]
37. Investigating the Relationship between of Vascular Endothelial Growth Factor and HER-2neu in IHC Staining with Metastasis and Mortality in Patients with Osteosarcoma.
Aznab M; Khajevand Ahmady M; Jamshidi K; Madani SH; Khazaei S; Shoushtaryzadeh T; Bagheri A
Asian Pac J Cancer Prev; 2020 Oct; 21(10):3005-3009. PubMed ID: 33112560
[TBL] [Abstract][Full Text] [Related]
38. Novel HDGF/HIF-1α/VEGF axis in oral cancer impacts disease prognosis.
Lin YW; Huang ST; Wu JC; Chu TH; Huang SC; Lee CC; Tai MH
BMC Cancer; 2019 Nov; 19(1):1083. PubMed ID: 31711427
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of vascular endothelial growth factor (VEGF), VEGF receptor 2, platelet-derived growth factor-β (PDGF-β), and PDGF-β receptor expression in papillary renal cell carcinoma.
Kim M; Sohn M; Shim M; Choi SK; Park M; Kim E; Go H; Park Y; Cho YM; Ro JY; Jeong IG; Song C; Hong JH; Kim CS; Ahn H
Hum Pathol; 2017 Mar; 61():78-89. PubMed ID: 27989785
[TBL] [Abstract][Full Text] [Related]
40. SDF-1 Expression is Associated with Poor Prognosis in Osteosarcoma.
Yu D; Lv F; Zhang J; Li H
Ann Clin Lab Sci; 2016 Sep; 46(5):508-14. PubMed ID: 27650618
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
